Try GOLD - Free

MIND-ALTERING KETAMINE BECOMES NEW PAIN TREATMENT, DESPITE LITTLE RESEARCH OR REGULATION

AppleMagazine

|

AppleMagazine #628

As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy.

MIND-ALTERING KETAMINE BECOMES NEW PAIN TREATMENT, DESPITE LITTLE RESEARCH OR REGULATION

Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions. The generic drug can be purchased cheaply and prescribed by most physicians and some nurses, regardless of their training.

With limited research on its effectiveness against pain, some experts worry the U.S. may be repeating mistakes that gave rise to the opioid crisis: overprescribing a questionable drug that carries significant safety and abuse risks.

"There's a paucity of options for pain and so there's a tendency to just grab the next thing that can make a difference," said Dr. Padma Gulur, a Duke University pain specialist who is studying ketamine's use. "A medical journal will publish a few papers saying, 'Oh, look, this is doing good things, and then there's rampant off-label use, without necessarily the science behind it."

When Gulur and her colleagues tracked 300 patients receiving ketamine at Duke, more than a third of them reported significant side effects that required professional attention, such as hallucinations, troubling thoughts and visual disturbances.

Ketamine also didn't result in lower rates of opioid prescribing in the months following treatment, a common goal of therapy, according to Gulur. Her research is under review for medical journal publication.

PSYCHEDELIC EXPERIENCE

Ketamine was approved more than 50 years ago as a powerful anesthetic for patients undergoing surgery. At lower doses, it can produce psychedelic, out-of-body experiences, which made it a popular club drug in the 1990s. With its recent adoption for pain, patients are increasingly encountering those same effects..

MORE STORIES FROM AppleMagazine

AppleMagazine

AppleMagazine

APPLE'S SHIFT TO ESIM-ONLY DEVICES ACCELERATES GLOBAL TREND IN MOBILE CONNECTIVITY

Apple's decision to make its flagship iPhones eSIM-only in key markets is rippling across the mobile industry, accelerating a shift away from physical SIM cards and pushing carriers worldwide to adapt faster than expected.

time to read

2 mins

September 12, 2025

AppleMagazine

AppleMagazine

RESEARCHERS UNVEIL WORLD'S FIRST 6G CHIP CAPABLE OF OPERATING ACROSS ALL FREQUENCY BANDS

A team of researchers has announced a major breakthrough in wireless technology: the development of the world's first 6G chip designed to operate seamlessly across all frequency bands.

time to read

3 mins

September 12, 2025

AppleMagazine

AppleMagazine

MRBEAST REPORTEDLY PREPARING TO LAUNCH HIS OWN PHONE COMPANY AS CREATOR ECONOMY MOVES DEEPER INTO TECH

Jimmy Donaldson, better known as MrBeast, is reportedly working on one of his boldest ventures yet: launching a phone company.

time to read

3 mins

September 12, 2025

AppleMagazine

AppleMagazine

META AND TIΚΤΟΚ WIN LEGAL CHALLENGE AGAINST EU TECH FEES, DEALING BLOW TO REGULATORS

Meta and TikTok have successfully challenged a European Union plan to impose new fees on large technology companies, marking a significant setback for EU regulators who have sought to make Big Tech shoulder more of the costs of digital oversight.

time to read

2 mins

September 12, 2025

AppleMagazine

AppleMagazine

NVIDIA REPORTEDLY LIMITS RTX 5060 SERIES SUPPLY TO BOARD PARTNERS IN BID TO KEEP PRICES STABLE

NVIDIA is once again flexing its market power to shape the GPU landscape.

time to read

3 mins

September 12, 2025

AppleMagazine

AppleMagazine

NEURALINK SAYS 12 PEOPLE HAVE RECEIVED ITS BRAIN IMPLANTS

Elon Musk’s brain-computer interface startup Neuralink has confirmed that it has now implanted its device in 12 people, marking its most significant step yet toward testing the safety and functionality of its technology in humans.

time to read

2 mins

September 12, 2025

AppleMagazine

AppleMagazine

APPLE SETS SEPTEMBER 15 LAUNCH FOR IOS 26, IPADOS 26, MACOS 26 TAHOE, AND OTHER MAJOR SOFTWARE UPDATES

Apple has confirmed that its next generation of operating systems—including iOS 26, iPadOS 26, macOS 26 Tahoe, watchOS 13, and visionOS 3—will roll out globally on September 15, 2025.

time to read

2 mins

September 12, 2025

AppleMagazine

AppleMagazine

APPLE'S AI STRATEGY TAKES CENTER STAGE AS IPHONE 17 LAUNCHES WITHOUT FULL SIRI OVERHAUL

Apple's iPhone 17 lineup has debuted, accompanied by its first wave of Apple Intelligence features, but one of the most anticipated upgrades—an entirely AI-powered Siri—remains absent.

time to read

3 mins

September 12, 2025

AppleMagazine

AppleMagazine

APPLE EXTENDS FREE SATELLITE CONNECTIVITY FOR IPHONE 14 AND 15 USERS BY ONE YEAR

Apple has announced that owners of the iPhone 14 and iPhone 15 will receive an extra year of free satellite connectivity, extending access to its Emergency SOS and related features through late 2025.

time to read

2 mins

September 12, 2025

AppleMagazine

AppleMagazine

MICROSOFT TO INCORPORATE ANTHROPIC AI AS IT SHIFTS PART OF STRATEGY BEYOND OPENAI

Microsoft, one of OpenAl's largest backers and its exclusive cloud partner, is now preparing to integrate Al models from Anthropic into some of its products and services, signaling a strategic diversification in its artificial intelligence partnerships.

time to read

2 mins

September 12, 2025

Translate

Share

-
+

Change font size